McIlwain Matthew S
SEC insider (Form 3/4/5 filer). CIK 0001381752. Director at Nautilus Biotechnology, Inc. (NAUT) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on Jun 18, 2026. Located in SEATTLE, WA.
Companies McIlwain Matthew S has filed insider reports for
- Nautilus Biotechnology, Inc. (NAUT): Director
- SMARTSHEET INC (SMAR): Director
McIlwain Matthew S
CIK: 0001381752
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)1 (33.3%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jun 18, 2026NAUT
Nautilus Biotechnology, Inc.
AwardDirectStock Option (Right to Buy)
45K shares- - Jun 23, 2025NAUT
Nautilus Biotechnology, Inc.
AwardDirectStock Option (Right to Buy)
45K shares- - Jan 22, 2025SMAR
SMARTSHEET INC
DispositionDirect131.1K shares at avg. $56.50$7.4M
1-3 of 3 transactions